Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Dermoscopy helped diagnose discoid lupus erythematosus in two patients without needing skin biopsies.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Oral ulcers are common in SLE patients and often link to other symptoms.

Early identification of lupus through skin signs and blood tests is crucial in India.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Most patients with systemic lupus erythematosus in Malwa, India, show skin symptoms like photosensitivity and rashes.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Hair chemicals don't cause SLE but may increase skin issues in those with SLE.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.